Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR000135)
Received: 2 November 2018
Accepted: 16 January 2019
First Online: 31 January 2019
Ethics approval and consent to participate
: The study was approved by the Mayo Clinic Institutional Review Board (IRB).
: Not applicable
: Raymond J. Gibbons is a consultant at Astellas Pharm and Peer View Institute. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.